Inferensys

Glossary

Regulatory Explainability

The specific requirements and standards for model transparency and interpretability mandated by health authorities like the FDA or under regulations like MDR, ensuring that clinical AI decisions can be audited and validated for safety and efficacy.
Auditor reviewing AI-generated audit trail on laptop, blockchain-like immutable records visible, home office evening.
AUDITABLE CLINICAL AI

What is Regulatory Explainability?

Regulatory explainability defines the mandatory technical and procedural standards that render clinical AI decision-making transparent, auditable, and validatable for health authority clearance.

Regulatory explainability is the specific set of interpretability requirements mandated by health authorities—such as the FDA or under the EU MDR—that compel a Software as a Medical Device (SaMD) to produce auditable, human-intelligible justifications for every diagnostic output. It transforms abstract feature attribution into a compliance artifact, ensuring that a model's reasoning can be rigorously validated for safety and efficacy during pre-market review and post-market surveillance.

This discipline mandates a complete SaMD audit trail, linking each prediction to a faithful saliency map or lesion attribution that demonstrates the algorithm focused on clinically relevant pathology rather than confounding artifacts. The goal is trust calibration and the elimination of the interpretability illusion, providing regulators with quantitative faithfulness scores and clinician-in-the-loop workflows that prove the system's decisions are reproducible, causally sound, and safe for clinical use.

AUDITABLE AI FRAMEWORKS

Core Components of Regulatory Explainability

The foundational technical and procedural pillars required to satisfy FDA, MDR, and global health authority mandates for transparent, auditable clinical AI systems.

02

Faithfulness Score

A quantitative metric that evaluates whether an explanation accurately reflects the model's true reasoning process. It measures the correlation between attributed feature importance and the actual change in model output when those features are perturbed or occluded.

  • Perturbation-based: Measures output drop when top-k attributed pixels are removed
  • Comprehensiveness: Quantifies if the explanation captures all necessary features
  • Sufficiency: Verifies if the explanation alone is enough for the prediction
  • Essential for proving clinical validity to notified bodies
>0.85
Minimum Faithfulness Threshold
04

Interpretability Illusion

The dangerous false sense of security arising from a plausible-looking but unfaithful saliency map. A heatmap may highlight anatomically convincing regions while masking the model's reliance on spurious correlations or confounding artifacts.

  • Can be induced by attribution attacks that manipulate explanations
  • Detected through systematic ablation studies and faithfulness testing
  • A key risk flagged in FDA's Good Machine Learning Practice (GMLP)
  • Mitigated by using multiple orthogonal explanation methods (e.g., SHAP + Grad-CAM)
05

Domain-Specific Saliency Constraints

Explanation methods that incorporate anatomical priors and clinical knowledge to ensure saliency maps are physiologically plausible. This prevents models from highlighting irrelevant regions like imaging table edges or patient clothing.

  • Uses anatomical atlases as spatial priors for brain, lung, and cardiac imaging
  • Explanation regularization penalizes activations outside known organ boundaries
  • Aligns with radiomics feature extraction standards
  • Critical for demonstrating lesion attribution to regulatory reviewers
06

Post-Hoc Explainability Requirements

Regulatory frameworks mandate that explanation methods must be applied without modifying the underlying diagnostic model's architecture or training process. This preserves the frozen, validated state of the cleared algorithm.

  • Grad-CAM and Integrated Gradients operate on trained weights
  • Avoids the need for concept bottleneck models that require retraining
  • Supports change control documentation for SaMD submissions
  • Enables retrospective explainability on legacy deployed models
REGULATORY COMPLIANCE

Frequently Asked Questions

Clear answers to the most common questions about regulatory requirements for explainable AI in medical imaging, covering FDA expectations, MDR standards, and audit documentation.

The FDA does not mandate a specific explainability algorithm but requires that a Software as a Medical Device (SaMD) provides sufficient transparency for clinicians to understand and verify its outputs. Under the FDA's Total Product Lifecycle (TPLC) approach, manufacturers must demonstrate that the model's reasoning is auditable and that its decision-making process aligns with established clinical knowledge. This is typically satisfied through comprehensive documentation of the model's development, including feature attribution validation, saliency map analysis, and clinical performance studies that prove the device is safe and effective. The FDA's 2021 Artificial Intelligence/Machine Learning Action Plan emphasizes the need for transparency about the data used for training and the model's limitations, making post-hoc explainability methods like Grad-CAM and SHAP critical components of a premarket submission.

Prasad Kumkar

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.